The global Veterinary Care market size was reached at USD 80.5 billion in 2020 and is projected to surpass US$ 214.5 billion by 2030, expanding growth at a CAGR of 8.4% from 2021 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38409
Growth Factors
Increasing number of government initiatives to safeguard food security is likely to boost the adoption of better veterinary care worldwide. A significant increase in pet adoption and humanization worldwide is mostly responsible for the high need for veterinary care, which is boosting the market growth.
Moreover, the COVID-19 pandemic resulted in increased adoption of pets. In June 2020, at the Society for the Prevention of Cruelty to Animals Los Angeles, pet adoptions were double their normal rate, with almost 10 or 13 adoptions a day. Furthermore, a waiting list had formed for certain types of canines and puppies, as so few were left. Increasing awareness among pet owners for primary check-ups of their pets is further boosting the market.
Report Highlights
The companion animals segment held the largest revenue share of over 70.00% of the global market in 2020. This can be attributed to the growing initiatives by market players, rising pet population, and increasing pet expenditure.
The primary care segment held the largest revenue share of over 68% among the companion animal segment. Primary care includes physical examinations, vaccinations, lab testing, parasite prevention, diagnostic testing, behavioral counseling, training, diet, dental health & cleaning among others. According to the American Veterinary Medical Association (AVMA), nearly 80% of dogs develop some form of periodontal disease by the time they are 3 years old. Hence, the demand for dental care services is expected to increase.
North America dominated the market with a revenue share of over 52% in 2020. The rising incidence of canine disorders is one of the key factors responsible for the largest market share of the region. According to Banfield Pet Hospital’s 2018 State of Pet Health Report, over the past 10 years, there has been a significant increase in flea allergy cases and a 40.7% & 21.5% increase in environmental allergy cases in dogs and cats, respectively.
| Report Coverage | Details |
| Market Size | US$ 214.5 billion by 2030 |
| Growth Rate | CAGR of 8.4% From 2021 to 2030 |
| Base Year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Animal Type, Type of care |
| Regional Scope | North America, Latin America, Europe, Asia Pacific, MEA |
| Companies Mentioned | Merck Animal Health; Ceva Santé Animale; Zoetis; Boehringer Ingelheim GmbH; Elanco; IDEXX Laboratories, Inc.; Heska Corporation; Virbac; Vetoquinol S.A.; Indian Immunologicals Ltd. |
Key Players
- Merck Animal Health
- Ceva Santé Animale
- Zoetis
- Boehringer Ingelheim GmbH
- Elanco
- IDEXX Laboratories, Inc.
- Heska Corp.
- Virbac
- Vetoquinol S.A.
- Indian Immunologicals Ltd.
Market Segmentation
- Animal Type Outlook
- Companion Animal
- Dogs
- Cats
- Equine
- Others
- Production Animal
- Companion Animal
- Type Of Care Outlook
- Companion Animal
- Primary
- Emergency
- Critical
- Specialty Services
- Production Animal
- Primary
- Emergency
- Critical
- Specialty services
- Companion Animal
- Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- Middle East and Africa
- South Africa
- North America
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38409
Reasons to Purchase this Report:
– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Veterinary Care Market, By Animal Type
7.1. Veterinary Care Market, by Animal Type, 2021-2030
7.1.1. Companion Animal
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Production Animal
7.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Veterinary Care Market, By Type Of Care
8.1. Veterinary Care Market, by Type Of Care, 2021-2030
8.1.1. Companion Animal
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Production Animal
8.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Veterinary Care Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Animal Type (2016-2030)
9.1.2. Market Revenue and Forecast, by Type Of Care (2016-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Animal Type (2016-2030)
9.1.3.2. Market Revenue and Forecast, by Type Of Care (2016-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Animal Type (2016-2030)
9.1.4.2. Market Revenue and Forecast, by Type Of Care (2016-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Animal Type (2016-2030)
9.2.2. Market Revenue and Forecast, by Type Of Care (2016-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Animal Type (2016-2030)
9.2.3.2. Market Revenue and Forecast, by Type Of Care (2016-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Animal Type (2016-2030)
9.2.4.2. Market Revenue and Forecast, by Type Of Care (2016-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Animal Type (2016-2030)
9.2.5.2. Market Revenue and Forecast, by Type Of Care (2016-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Animal Type (2016-2030)
9.2.6.2. Market Revenue and Forecast, by Type Of Care (2016-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Animal Type (2016-2030)
9.3.2. Market Revenue and Forecast, by Type Of Care (2016-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Animal Type (2016-2030)
9.3.3.2. Market Revenue and Forecast, by Type Of Care (2016-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Animal Type (2016-2030)
9.3.4.2. Market Revenue and Forecast, by Type Of Care (2016-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Animal Type (2016-2030)
9.3.5.2. Market Revenue and Forecast, by Type Of Care (2016-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Animal Type (2016-2030)
9.3.6.2. Market Revenue and Forecast, by Type Of Care (2016-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Animal Type (2016-2030)
9.4.2. Market Revenue and Forecast, by Type Of Care (2016-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Animal Type (2016-2030)
9.4.3.2. Market Revenue and Forecast, by Type Of Care (2016-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Animal Type (2016-2030)
9.4.4.2. Market Revenue and Forecast, by Type Of Care (2016-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Animal Type (2016-2030)
9.4.5.2. Market Revenue and Forecast, by Type Of Care (2016-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Animal Type (2016-2030)
9.4.6.2. Market Revenue and Forecast, by Type Of Care (2016-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Animal Type (2016-2030)
9.5.2. Market Revenue and Forecast, by Type Of Care (2016-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Animal Type (2016-2030)
9.5.3.2. Market Revenue and Forecast, by Type Of Care (2016-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Animal Type (2016-2030)
9.5.4.2. Market Revenue and Forecast, by Type Of Care (2016-2030)
Chapter 10. Company Profiles
10.1. Merck Animal Health
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Ceva Santé Animale
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Zoetis
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Boehringer Ingelheim GmbH
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Elanco
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. IDEXX Laboratories, Inc.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Heska Corp.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Virbac
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Vetoquinol S.A.
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Indian Immunologicals Ltd.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38409
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
